TNGXNasdaq United States
Market cap
$3.916 B
$27.07 -6.65%
Close of 7 Aug 2026
Revenue
$62.4M
#2673 by revenue
Earnings
-$101.6M
Loss-making
Shares outstanding
142,688,851
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Tango Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.